HaploX

HaploX is a national high-tech enterprise specializing in tumor liquid biopsy and genetic big data, with core technological advantages in gene sequencing, liquid biopsy, life information, and big data.

Its medical laboratory is equipped with advanced gene sequencing platforms and has established a comprehensive quality management system. It has obtained certifications from authoritative domestic and international organizations such as CAP (College of American Pathologists), CLIA (Clinical Laboratory Improvement Amendments), EMQN (European Molecular Genetics Quality Network), and NCCL (National Center for Clinical Laboratories). Its business covers the entire course of tumor management, genetic disease screening, major infectious diseases, and medical system technology, providing gene testing technical services and overall solutions to hundreds of tertiary hospitals, research institutes, health examination institutions, insurance companies, and local governments across the country.

Corporate Vision
Benefit humanity through technological innovation, enabling every life to be healthy for 120 years

Core Values
Patients first; customer-centric; based on continuous strivers

HaploX Talent Philosophy
Aggressive, pursuing excellence; Technology, advocating science and daring to create; Creative, being different and pioneering innovation; Globalization, embracing the world and changing the world

We provide excellent talents with welfare housing, talent subsidies, rich corporate cultural activities, and complete promotion channels.